Literature DB >> 33603960

Novel Quinazolinyl Compounds as Endoribonuclease Inositol Requiring Enzyme 1 (IRE 1α) Inhibitors for Treating Cancer.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 33603960      PMCID： PMC7883370          DOI： 10.1021/acsmedchemlett.0c00678

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  5 in total

Review 1.  The emerging role of XBP1 in cancer.

Authors:  Shanshan Chen; Jing Chen; Xin Hua; Yue Sun; Rui Cui; Jun Sha; Xiaoli Zhu
Journal:  Biomed Pharmacother       Date:  2020-04-12       Impact factor: 6.529

Review 2.  Endoplasmic reticulum stress signaling in cancer and neurodegenerative disorders: Tools and strategies to understand its complexity.

Authors:  Daniela Correia da Silva; Patrícia Valentão; Paula B Andrade; David M Pereira
Journal:  Pharmacol Res       Date:  2020-02-14       Impact factor: 7.658

Review 3.  Pharmacological Targeting of IRE1 in Cancer.

Authors:  Diana Pelizzari Raymundo; Dimitrios Doultsinos; Xavier Guillory; Antonio Carlesso; Leif A Eriksson; Eric Chevet
Journal:  Trends Cancer       Date:  2020-08-26

Review 4.  Endoplasmic Reticulum Stress Signaling in Cancer Cells.

Authors:  Scott A Oakes
Journal:  Am J Pathol       Date:  2020-02-27       Impact factor: 4.307

Review 5.  Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer.

Authors:  María A Rodríguez-Hernández; P de la Cruz-Ojeda; Mª José López-Grueso; Elena Navarro-Villarán; Raquel Requejo-Aguilar; Beatriz Castejón-Vega; María Negrete; Paloma Gallego; Álvaro Vega-Ochoa; Victor M Victor; Mario D Cordero; José A Del Campo; J Antonio Bárcena; C Alicia Padilla; Jordi Muntané
Journal:  Redox Biol       Date:  2020-05-23       Impact factor: 11.799
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.